Maximum quantity allowed is 999
请选择数量
CAS RN: 99011-02-6 | 產品號碼: I0747
補充產品訊息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
產品號碼 | I0747 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__1__4H__1__6N__4 = 240.31 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 | 100MG-Glass Bottle with Plastic Insert (閲覽圖片), 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 99011-02-6 |
Reaxys-RN | 7710060 |
PubChem Substance ID | 87561300 |
Merck Index(14) | 4922 |
MDL編號 | MFCD00866946 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
性質
熔點 | 294 °C |
Maximum Wavelength | 245 nm (H__2O/MeOH) |
GHS
圖形表示 |
![]() |
信號詞 | Danger |
危險性說明 | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
RTECS # | NJ5903450 |
運輸資料
UN編號 | UN2811 |
類別 | 6.1 |
包裝類別 | III |
HS編碼* | 2933.99-000 |
Application
Imiquimod: A Toll-Like Receptor (TLR) 7 Agonist and a Potent Immune Activator
Imiquimod is reported as a Toll-like receptor (TLR) 7 agonist and a potent immune activator. Imiquimod activates innate immune cells to produce interferon-α (IFN-α) and other cytokines both in vitro and in vivo. This immune-based mechanism provides activity against a number of viruses. In addition, it is also used for a reagent for inflammation and immunity disorder models. (The product is for research purpose only.)
References
- Imiquimod applied topically: a novel immune response modifier and new class of drug
- Imiquimod and resiquimod as novel immunomodulators
- Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
- Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
考研文獻
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。